Monograph 29 · ERD-INJ-28
Retatrutide Single Chamber
A single-chamber pen — 10 mg once weekly.
Retatrutide is a peptide triple agonist at the GLP-1, GIP and glucagon receptors, given once a week under the skin. This presentation is a single-chamber adjustable-dose pen: the solution is already in the pen, and each dose is set to the 10 mg marked on the carton.
The pen holds 30 mg. The carton contains that one pen and 10 disposable needles, and it is serialised for export. Keep it refrigerated, do not freeze it, and use a new needle for every injection.
- INN
- Retatrutide
- Class
- Triple agonist · GLP-1, GIP and glucagon receptors
- Category
- Pens
- Form
- Solution for injection, pen
- Strength
- 30 mg
- Pack
- 1 adjustable-dose pen · 10 needles
- GTIN
- 05012345678929
Each single-chamber adjustable-dose pen contains retatrutide 30 mg as a solution for injection, labelled to deliver 10 mg per dose, once weekly. The carton contains 1 pen and 10 disposable needles.
For patients
Package leaflet →
The plain-language leaflet from inside the pack.
For healthcare professionals
Product information →
The full document in SmPC order, ready to print.
Ergopharm Advanced Research Centre, Tandalja, Vadodara, Gujarat 390012, India. For Export Only. All products are prescription-only and for use under medical supervision.